Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis
- 31 October 1999
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 83 (4) , 311-317
- https://doi.org/10.1016/s1081-1206(10)62671-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Fexofenadine hydrochloride in the treatment of chronic idiopathic urticaria: A placebo-controlled, parallel-group, dose-ranging studyJournal of Dermatological Treatment, 1998
- Efficacy and Safety of Fexofenadine Hydrochloride for Treatment of Seasonal Allergic RhinitisAnnals of Allergy, Asthma & Immunology, 1997
- Overview of comorbid associations of allergic rhinitis☆☆☆★Journal of Allergy and Clinical Immunology, 1997
- Clinical comparison of histamine H1–receptor antagonist drugsJournal of Allergy and Clinical Immunology, 1996
- The Role of Outcome Studies in Allergy and Clinical ImmunologyAllergy and Asthma Proceedings, 1996
- Interpretation of rhinoconjunctivitis quality of life questionnaire dataJournal of Allergy and Clinical Immunology, 1996
- Learning Impairment and Allergic RhinitisAllergy and Asthma Proceedings, 1996
- Work, Classroom and Activity Impairment InstrumentsClinical Drug Investigation, 1996
- The Validity and Reproducibility of a Work Productivity and Activity Impairment InstrumentPharmacoEconomics, 1993
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992